Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Found 125 studies with search of: | "Proteinuria" |
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Active, not recruiting |
To Assess the Effects of Valsartan on Albuminuria/Proteinuria in Hypertensive Patients With Type 2 Diabetes Mellitus
|
||||
2 | Recruiting |
The Efficacy and Safety of Calcitriol for the Treatment of Lupus Nephritis and Persistent Proteinuria
|
||||
3 | Not yet recruiting |
Specific Blockage of Angiotensine 2 and Podocyturia in Glomerular Nephropathies With Hypertension and Proteinuria
|
||||
4 | Completed |
Effect of Valsartan on Proteinuria in Patients With Hypertension and Diabetes Mellitus
|
||||
5 | Completed |
High Doses of Candesartan Cilexetil on the Reduction of Proteinuria
|
||||
6 | Active, not recruiting |
Study to Determine the Effects of Losartan on Proteinuria in Pediatric Patients
|
||||
7 | Completed |
The Effect of Renin Angiotensin System Blockage (RAS) Blockade On PTX3 Levels In Diabetic Patients With Proteinuria
|
||||
8 | Completed |
Use of Mucomyst to Ameliorate Oxidant Stress in Diabetics With Proteinuria
|
||||
9 | Completed |
Optimalization of Nephroprotection Using Agents Inhibiting Renin-Angiotensin-Aldosterone System
|
||||
10 | Completed |
Optimalization of Nephroprotection Using Atorvastatin (Sortis)
|
||||
11 | Completed |
Olmesartan Medoxomil and Diabetic Nephropathy
|
||||
12 | Active, not recruiting |
Sitaxsentan in Proteinuric Chronic Kidney Disease
|
||||
13 | Completed |
Optimalization of Nephroprotection Using N-Acetylcysteine
|
||||
14 | Completed |
Using the Drug Spironolactone to Test If It Reduces Protein Leakage From the Kidney
|
||||
15 | Recruiting |
The Fabrazyme® and Arbs and ACE Inhibitor Treatment (FAACET) Study
|
||||
16 | Active, not recruiting |
ORIENT: Olmesartan Reducing Incidence of End Stage Renal Disease in Diabetic Nephropathy Trial
|
||||
17 | Completed |
Endothelin Receptor Antagonism in Proteinuric Nephropathy
|
||||
18 | Completed |
Pirfenidone to Treat Kidney Disease (Focal Segmental Glomerulosclerosis)
|
||||
19 | Completed |
Tarka® vs. Lotrel® in Hypertensive, Diabetic Subjects With Renal Disease (TANDEM)
|
||||
20 | Completed |
Antiproteinuric Agents and Fabry Disease
|
Previous Page | Studies Shown (1-20) | Next (21-40) |